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Background
During the last 3 years, new routes of HIV infection have
been reported in our country: addiction and homosexual-
ity. Heroin use and the new ethnobotanic drugs (so called
“legal drugs”) led to a dramatic increase in mortality in
these intravenous drug users (IVDUs). A European multi-
centre study showed how IVDUs with recent HIV sero-
conversion are subject to an increased risk of mortality
due to pneumonia, endocarditis, sepsis, meningitis, ence-
phalitis, and decompensated liver cirrhosis. Before the
availability of HAART, an increased rate of mortality due
to heroin overdose and suicide was also recorded among
HIV-infected IVDUs. Just the use of elevated heroin
dosages associated to a suicidal behavior could be partially
responsible for this phenomenon in patients with a newly
diagnosed HIV disease and lacking social and psychologi-
cal support, especially before the introduction of effective
antiretroviral drug combinations (HAART).
The objective of our study was to evaluate the temporal
trend of deaths in a cohort of IVDUs, newly infected with
HIV and admitted to our clinic and to assess its relation-
ship with HIV infection and AIDS, and availability of
potent antiretroviral therapy.
Methods
The investigation of the death condition of HIV infected
IVDUs was conducted through a retrospective cohort
study in the Clinical Hospital of Infection and Tropical
Diseases “Dr. Victor Babeş”, Casa Andreea, from 01 Janu-
ary 2011 to 31 August 2013. A clinical and etiological
analysis of different disorders was done. We excluded the
patients missing to follow up and those who died at home.
Results
Out of a total of 249 patients, 32 (13%) IVDUs died
(mainly ethnobotanic addicts, 66%), 23 males and
9 females. The large majority of enrolled subjects were
born in the Bucharest metropolitan area and surround-
ings. The mean age at death was 30 years old (limit
18-50). The median value of CD4 lymphocytes was 96/
cmm. Most of the patients were unemployed and had no
education (only primary school). The main death causes
were as follows: AIDS (65.6%), ethnobotanic drug over-
dose (6.2%), sepsis with methicillin susceptible Staphylo-
coccus aureus (37.5%), pulmonary or disseminated
tuberculosis (28.1%), pneumonia (18.75%) and few cases
of other diseases. Only one IVDU received antiretroviral
treatment, without adherence.
Conclusion
Stopping drug use, psychological counseling, early diagno-
sis of HIV status, counseling and social support, initiating
tuberculosis and antiretroviral treatment, are some of the
measures to be taken to decrease both the number of
IVDUs and their death.
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